INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 47 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $14,000 | -6.7% | 14,176 | 0.0% | 0.00% | – |
| Q3 2019 | $15,000 | -42.3% | 14,176 | 0.0% | 0.00% | – |
| Q2 2019 | $26,000 | -3.7% | 14,176 | 0.0% | 0.00% | – |
| Q1 2019 | $27,000 | +58.8% | 14,176 | 0.0% | 0.00% | – |
| Q4 2018 | $17,000 | -55.3% | 14,176 | 0.0% | 0.00% | – |
| Q3 2018 | $38,000 | +40.7% | 14,176 | 0.0% | 0.00% | – |
| Q2 2018 | $27,000 | -10.0% | 14,176 | 0.0% | 0.00% | – |
| Q1 2018 | $30,000 | +3.4% | 14,176 | 0.0% | 0.00% | – |
| Q4 2017 | $29,000 | -70.4% | 14,176 | -80.8% | 0.00% | -100.0% |
| Q3 2017 | $98,000 | +28.9% | 73,916 | +51.9% | 0.00% | +100.0% |
| Q2 2017 | $76,000 | -31.5% | 48,666 | +41.1% | 0.00% | -50.0% |
| Q1 2017 | $111,000 | +136.2% | 34,490 | 0.0% | 0.00% | +100.0% |
| Q4 2016 | $47,000 | – | 34,490 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 6,353,645 | $4,017,000 | 0.19% |
| Gratus Capital, LLC | 1,117,154 | $706,000 | 0.08% |
| Bleichroeder LP | 250,000 | $158,000 | 0.03% |
| Polar Capital Holdings Plc | 5,000,000 | $3,162,000 | 0.02% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $345,000 | 0.01% |
| Ergoteles LLC | 419,652 | $265,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 249,000 | $157,000 | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 41,396 | $26,000 | 0.00% |
| Heritage Financial Services, LLC | 4,749 | $3,000 | 0.00% |
| Evercore Wealth Management, LLC | 143,138 | $91,000 | 0.00% |